Ascorbic acid supplementation restores defective leukocyte-endothelial interaction in alloxan-daibetic rats

Diabetes/Metabolism Research and Reviews

Volumn 19, Issue 1, 2003, Pages 60-68

  Zanardo, Renata Cristina Onishi ^a   Costa Cruz, José Walber Miranda ^a   Aparecida de Oliveira, Maria ^a   Fortes, Zuleica Bruno ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Ascorbic acid; Diabetes mellitus; ICAM 1 expression; Leukocyte endothelial interaction

Indexed keywords

ALLOXAN; ASCORBIC ACID; CARRAGEENAN; INTERCELLULAR ADHESION MOLECULE 1; LEUKOTRIENE B4; REACTIVE OXYGEN METABOLITE; ZYMOSAN;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INTERACTION; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ERYTHROCYTE PARAMETERS; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; LEUKOCYTE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SHEAR RATE; SPERMATID; TESTIS; VENULE; VITAMIN SUPPLEMENTATION;

EID: 0037214960     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.339     Document Type: Article

References (46)

1. Rayfield EJ, Ault MJ, Keush GT, Brothers MJ, Nechemias C, Smith H. Infections and diabetes: the cause of glucose control. Am J Med 1982; 72: 439-450.
2. Bagdade JD, Root RK, Bulger RJ. Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes 1974; 23: 9-15.
3. Garcia-Leme J, Hamamura L, Migliorini RH, Leite MP. Influence of diabetes upon the inflammatory response of the rat. A pharmacological analysis. Eur J Pharmacol 1973; 23: 74-81.
4. Fortes ZB, Garcia-Leme J, Scivoletto R. Influence of diabetes on the reactivity of mesenteric microvessels to histamine, bradykinin and acetylcholine. Br J Pharmacol 1983; 78: 39-48.
5. Pereira MAA, Sannomiya P, Garcia-Leme J. Inhibition of leukocyte chemotaxis by factor in alloxan-induced diabetic rat plasma. Diabetes 1987; 36: 1307-1314.
6. Fortes ZB, Farsky SP, Oliveira MA, Garcia-Leme J. Direct vital microscopic study of defective leukocyte-endothelial interaction in diabetes mellitus. Diabetes 1991; 40: 1267-1273.
7. Sannomiya P, Oliveira MA, Fortes ZB. Aminoguanidine and the prevention of leukocyte dysfunction in diabetes mellitus: a direct vital microscopic study. Br J Pharmacol 1997; 122: 894-898.
8. Cruz JWMC, Oliveira MA, Hohman TC, Fortes ZB. Influence of tolrestat on the defective leukocyte-endothelial interaction in experimental diabetes. Eur J Pharmacol 2000; 391: 163-174.
9. Chen MS, Hutchinson ML, Pecoraro RE, Lee WYL, Labbé RF. Hyperglycemia-induced intracellular depletion of ascorbic acid in human mononuclear leukocytes. Diabetes 1983; 32: 1978-1081.
10. Yue DK, McLennan S, Fisher E, et al. Ascorbic acid metabolism and polyol pathway in diabetes. Diabetes 1989; 38: 257-261.
11. Akkus I, Hüseyin V, Çaglayan O, Menekse E, Can G, Durmus B. Leukocyte lipid peroxidation, superoxide dismutase, glutathione peroxidase and serum vitamin C levels of patients with type II diabetes mellitus. Clin Chim Acta 1996; 244: 221-227.
12. Cunningham JJ, Mearkle PL, Brown RG. Vitamin C: an aldose reductase inhibitor that normalizes erythrocyte sorbitol in insulin-dependent diabetes mellitus. Am J Coll Nutr 1994; 13: 344-350.
13. Davie SJ, Gould BJ, Yudkin JS. Effect of vitamin C on glycosylation of proteins. Diabetes 1992; 41: 167-173.
14. Ting HH, Timini FK, Boles KS, Creager SJ, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. J Clin Invest 1996; 97: 22-28.
15. Timini FK, Ting HH, Haley EA, Roddy MA, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. J Am Coll Cardiol 1998; 31: 552-557.
16. Simán CM, Eriksson UJ. Vitamin C supplementation of the maternal diet reduces the rate of malformation in the offspring of diabetic rats. Diabetologia 1997; 40: 1416-1424.
17. Rhodin JAG. Architecture of the vessel wall. In Handbook of Physiology. The Cardiovascular System, vol. II Bohr DF, Somlyo AP, Sparks HV (eds). The American Physiological Society: Bethesda, MD, 1986; 1-31.
18. Davis MJ. Determination of volumetric flow in capillary tubes using an optical Doppler velocimeter. Microvasc Res 1987; 34: 223-230.
19. Bucana C, Saiki I, Nayer R. Uptake and accumulation of the vital dye hydroethidine in neoplastic cells. J Histochem Cytochem 1986; 34: 1109-1115.
20. Suzuki H, Swei A, Zweifach BW, Schmidt-Schönbein GW. In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats. Hydroethidine microfluorography. Hypertension 1995; 25: 1083-1089.
21. Dantas APV, Tostes RCA, Fortes ZB, Costa SG, Nigro D, Carvalho MHC. In vivo evidence for antioxidant potential of estrogen in microvessels of female spontaneously hypertensive rats. Hypertension 2002; 39: 405-411.
22. 2 integrins and intracellular adhesion molecule type 1 in inflammation. In Physiology and Pathophysiology of Leukocyte Adhesion, Granger DN, Schmid-Schöenbein GW (eds). Oxford University Press: New York, 1995; 3-42.
23. Schmid-Schöeinbein GW, Fung YC, Zweifach BW. Vascular endothelium-leukocyte interaction, sticking shear force in venules. Circ Res 1975; 36: 173-184.
24. Ley K, Gaehtgens P. Endothelial, not hemodynamic differences are responsible for preferential leukocyte rolling in rat mesenteric venules. Circ Res 1991; 69: 1034-1041.
25. Perry MA, Granger DN. Role of CD11/CD18 in shear rate-dependent leukocyte-endothelial cell interactions in cat mesenteric venules. J Clin Invest 1991; 87: 1798-1804.
26. Lawrence MB, Smith CW, Eskin SG, McIntyre LV. Effect of venous shear stress on CD18-mediated neutrophil adhesion to cultured endothelium. Blood 1990; 75: 227-237.
27. Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J 1994; 8: 504-512.
28. Abassi O, Kishimoto JK, McIntire LV, Anderson DC, Smith CW. E-selectin supports neutrophil rolling in vitro under conditions of flow. J Clin Invest 1993; 92: 2719-2730.
29. Jones DA, Abassi O, McIntyre LV, McEver RP, Cotran RS, Gimbrone MA. P-selectin mediates neutrophil rolling on histamine-stimulated endothelial cells. Biophys J 1993; 65: 1560-1569.
30. 2 integrins in vivo. Proc Natl Acad Sci USA 1991; 88: 7538-7542.
31. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL-1 and interferon γ: tissue distribution, biochemistry and function of a natural adherence molecule (ICAM-1). J Immunol 1986; 137: 245-254.
32. Norris P, Poston RN, Thomas DS, Thornhill M, Hawk J, Haskard DO. The expression of endothelial-leukocyte adhesion molecule-1 (ELAM-1), intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in experimental cutaneous inflammation: a comparison of ultraviolet erythema and delayed hypersensitivity. J Invest Dermatol 1991; 96: 763-770.
33. Sannomiya P, Oliveira MA, Fortes ZB. Inhibition of leukocyte-endothelial interactions in diabetes mellitus: role of adhesion molecule ICAM-1. J Vasc Res 1996; 33(Suppl. 2): 6.
34. Fasching P, Veitl M, Rohac M, et al. Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1996; 81: 4313-4317.
35. Buckley CD, Adams DH, Simmons DI. Soluble leukocyte-endothelial adhesion molecules. In Physiology of Inflammation, Ley K (ed.). Oxford University Press: New York, 2001; 285-302.
36. Ohno N, Ichikawa H, Coe L, Kvietys PR, Granger DN, Alexander JS. Soluble selectins and ICAM-1 modulate neutrophil-endothelial adhesion and diapedesis in vitro. Inflammation 1997; 21: 313-324.
37. Gearing AJH, Newman W. Circulating adhesion molecules in disease. Immunol Today 1993; 14: 506-512.
38. Yabe-Nishimura C. Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications. Pharmacol Rev 1998; 50: 21-33.
39. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 1993; 88: 2510-2516.
40. Rodríguez-Mañas L, Angulo J, Peiró C, et al. Endothelial dysfunction and metabolic control in streptozotocin-induced diabetic rats. Br J Pharmacol 1998; 123: 1495-1502.
41. Hattori Y, Kawasaki H, Abe K, Kanno M. Superoxide dismutase recovers endothelium-dependent relaxation in diabetic rat aorta. Am J Physiol 1991; 261: H1086-H1094.
42. Pieper GM, Siebeneich W. Diabetes-induced endothelial dysfunction is prevented by long-term treatment with the modified iron chelator, hydroxyethyl starch conjugated-deferoxamine. J Cardiovasc Pharmacol 1997; 30: 734-738.
43. Levine M. New concepts in the biology and biochemistry of ascorbic acid. N Engl J Med 1986; 314: 892-902.
44. Brownlee M, Vlassara H, Cerami A. Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann Int Med 1984; 101: 527-537.
45. Collier A, Small M. The role of the polyol pathway in diabetes mellitus. Br J Hosp Med 1991; 45: 38-40.
46. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405-412.